ALXO — ALX ONCOLOGY HLDGS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ALX ONCOLOGY HLDGS INC (ALXO)
ALX ONCOLOGY HLDGS INC (ALXO) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $4M. Across recent filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ALXO
How many top investors track ALXO
A small number of top investors own this.
ALXO Ownership Composition
How ALX ONCOLOGY HLDGS INC is held across tracked investor types, based on reported 13F positions.
- Other98.0%
- Hedge Funds2.0%
Tracked investors reporting ALXO
- Izzy EnglanderMar 31, 2026Millennium ManagementShares2MValue$4M% Portfolio0.00%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares37KValue$74.2K% Portfolio0.00%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares41.1KValue$82.4K% Portfolio0.00%
Recent activity
- $3.7MFeb 17, 2026
- $4MMay 15, 2026
- New$22.8KFeb 17, 2026
- New$74.2KMay 15, 2026
- New$82.4KMay 15, 2026
- Sold$0(-100.00%)Feb 17, 2026
- New$105.2KNov 14, 2025
Frequently asked questions
- How many institutional investors hold ALXO?
- 3 tracked institutional investors disclosed a position in ALXO (ALX ONCOLOGY HLDGS INC) in their most recent 13F filing.
- Who is the largest institutional holder of ALXO?
- Izzy Englander, Millennium Management, holds the largest disclosed position in ALXO, valued at $4M.
- Did institutional ownership of ALXO increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 1 fully exited ALXO.
- Where does this ALXO ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.